Approval · Notice of Compliance 29561 · 2022
AROMASIN: Notice of Compliance 29561
Issued November 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29561
- Date
- November 25, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per Advisement Letter.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AROMASIN | Not yet assigned | — |
Medicinal ingredients
- EXEMESTANE 25 MG per TAB